论文部分内容阅读
目的:观察新辅助化疗治疗宫颈癌的疗效并探讨其临床意义。方法:对34例宫颈癌患者进行新辅助化疗,然后再进行手术治疗。结果:34例患者经过两个疗程的化疗后,完全缓解4例,部分缓解12例,稳定10例,进展8例,总治愈率76.47%。对患者进行术后的病理检查,发生淋巴结转移4例。结论:运用新辅助化疗对宫颈癌进行治疗是安全有效的,其作为一种新的治疗宫颈癌的手段,临床意义显著。
Objective: To observe the effect of neoadjuvant chemotherapy on cervical cancer and to explore its clinical significance. Methods: Thirty-four patients with cervical cancer received neoadjuvant chemotherapy before surgery. Results: After two courses of chemotherapy, 34 patients achieved complete remission in 4 cases, partial remission in 12 cases, stable in 10 cases and progression in 8 cases. The total cure rate was 76.47%. Postoperative pathological examination of patients, the occurrence of lymph node metastasis in 4 cases. Conclusion: It is safe and effective to use neoadjuvant chemotherapy to treat cervical cancer. As a new means of treating cervical cancer, the clinical significance is significant.